Follow us on
Welcome Guest! You are here: Home » Health
Wrong to assume that all cancer drugs are effective

Monday July 2, 2018 5:51 PM, ANI

Cancer Drugs

Washington: Not all cancer drugs works on patients suffering from the fatal disease.

The research findings by University of Otago shed much-needed light on why new immune checkpoint inhibitor therapies such as nivolumab and pembrolizumab - approved by the New Zealand Government for the first time in 2016 to treat metastatic melanoma - do not work on many patients.

The new immunotherapeutic drugs herald a significant advancement in a cure for cancer. But while they can be effective for some melanoma patients, for others the therapies do not work at all, and most eventually become resistant to immunotherapy treatments.

One of the key components of the immune checkpoint mechanism is a protein on the surface of cancer cells called PD-L1 which can potentially be receptive to or block immunotherapy.

The researchers were able to show that epigenetic modification-- DNA modifications that do not directly alter the DNA sequence but instead change the frequency by which a cell uses specific genes -- specifically DNA methylation, influences whether PD-L1 is expressed on the cancer cell surface.

"Currently, there are no reliable biomarkers for predicting benefit from immune therapy in melanoma and these are desperately needed in the clinic," said a researcher Chris Jackson.

Jackson added that biomarkers help in choosing patients who are likely to benefit and who are not.

"Many groups worldwide are searching for immune-therapy biomarkers and this Otago discovery of an epigenetic marker appears very promising," he added.

Jackson believes the findings will now need to be tested in people with melanoma undergoing treatment to see if this test can make it "from the bench to the bedside."

Another lead researcher Aniruddha Chatterjee says the findings suggest epigenetic therapies could be used in clinical trials in combination with immunotherapy in melanoma to treat patients. However, further trials would be needed before this could become a possibility.

Due to non-availability of robust biomarkers, it is difficult to predict a patient's response and also a relatively lesser understanding on the basis for resistance to immunotherapy treatment of melanoma.

There is a global effort to unlock the secrets behind resistance to immunotherapy and the Otago researchers believe they may have uncovered a key piece of the puzzle.

DNA methylation is an epigenetic mechanism that plays a key role in switching genes "on" or "off" and helps to determine cellular function. Generally, DNA methylation silences gene expression and has been implicated in cancer.

"Our research provides evidence that it is the global loss of DNA methylation that regulates constitutive expression of the immune checkpoint PD-L1 in melanoma," Chatterjee said.

The findings have been heralded by the researchers' peers internationally as "highly novel" and a major advance in understanding melanoma biology.

The study appears in iScience journal.

For all the latest News, Opinions and Views, download App

Select Langauge To Read in Urdu, Hindi, Marathi or Arabic

Share this page
More Headlines
43rd Anniversary: Revisiting The Role Of RSS During Emergency
Landmark day for Saudi women as Kingdom officially lifts driving ban Sunday
Quddus Sir spent his whole life craving for more Muslims in civil services, dies at 47
Haj Flight 2018: First batch of pilgrims from Rajasthan, Karnataka embark on August 01
The Man Who Once Sold Tea Later ‘Sold’ Dreams
UPSC Civil Services Main 2018 Time Table released; First paper on September 28
First Haj flight from Hyderabad Embarkation Point on August 01, 2018
Hapur Lynching: Cops seen in picture showing Muslim man being dragged transferred
Bombay HC admits Colonel Purohit's discharge application in Malegaon blast case
Now, have more fun on WhatsApp using this video, audio group calling feature
Instagram video service IGTV with vertical video design goes live from Friday
High altitude affect growth of long bones: Study
Jamia Masjid Shopian: An architectural marvel, now at the mercy of careless management
Kashmir Story and the battle of David vs Goliath
Israelis fume as Prince William’s itinerary lists Jerusalem as occupied territory
First Hajj 2018 flight from Delhi, Lucknow on July 14; from Varanasi on July 20
Government school teachers can now directly apply for National Teachers’ Award
First Hajj flight from Jammu & Kashmir will be on July 14, 2018
Haj 2018: First batch of pilgrims to fly from Mumbai, Nagpur and Aurangabad on July 29
Using Kashmir for electoral purpose will further isolate India at International forums
You should be stepping up, says UNHRC Chief as US steps down
 Post Comments
Note: By posting your comments here you agree to the terms and conditions of